CClinicalTrials.gg
CompletedNCT06072274Updated Jan 13, 2026

Efficacy of VR Educational Program on Empathy and Attitudes Toward Dementia in Caregivers

An interventional study of Virtual reality dementia simulation with guided reflection and Traditional dementia education (lecture) in Dementia and Caregiver Burden, sponsored by Taipei Medical University. Completed at 1 site in Taiwan. Open to participants aged 20 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-01-13.

Sponsored by Taipei Medical University · Not applicable, Interventional, and Supportive care

Phase
Not applicable
Study type
Interventional
Enrollment
227
Allocation
Randomized
Ages
20 Years to 100 Years
Sex
All
01

Study summary

This randomized controlled trial evaluated a single-session virtual reality (VR) dementia simulation with guided small-group reflection compared with a time-matched, instructor-led lecture. A total of 227 caregivers of people with a formal diagnosis of dementia were enrolled and randomized. Empathy and attitudes toward dementia were assessed at baseline, immediately after the session, and 1 month after the session. Caregiver burden and psychological distress were assessed at baseline and 1 month after the session.

Read the detailed description

This study used a parallel, two-arm randomized controlled design to evaluate a VR-based dementia simulation for caregiver education. A total of 227 caregivers of people with a formal diagnosis of dementia were enrolled and randomized to either (1) a single 3-hour VR dementia simulation delivered in three consecutive segments, each followed by guided small-group reflection (intervention), or (2) an instructor-led dementia education lecture of equal duration (control). Empathy and attitudes toward dementia were assessed at baseline, immediately post-session, and 1 month post-session. Caregiver burden and psychological distress were assessed at baseline and 1 month post-session.

02

Conditions studied

  • Dementia
  • Caregiver Burden
03

In context

Dementia

2,172 studies on the registry are indexed under Dementia; 541 are open to participants now.

This study's enrollment of 227 is above the median of 83 across 1,629 interventional studies indexed under Dementia.

Browse Dementia studies →

Lead sponsor

Taipei Medical University is the lead sponsor of 245 studies on the registry; 56 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Inclusion criteria

  1. Over 20 years;
  2. Speak Chinese;
  3. Currently providing care to a person with a formal diagnosis of dementia (paid formal caregivers or unpaid family caregivers).

Exclusion criteria

Exclusion Criteria:

  1. Those who are unable to use VR devices due to certain physical or mental situations;
  2. Those who have fear/disgust for VR devices;
  3. Those who feel dizzy after using VR devices;
  4. For family caregivers: the care recipient is currently residing in a care facility.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Outcomes assessor)
Enrollment
227 participants (actual)

Study arms

  • Experimental
    Virtual reality dementia simulation with guided reflection

    A single 3-hour virtual reality (VR) dementia simulation delivered in three consecutive segments, each followed by guided small-group reflection.

    Behavioral: Virtual reality dementia simulation with guided reflection

  • Active comparator
    Traditional dementia education (lecture)

    Traditional dementia education (lecture) of equal duration.

    Behavioral: Traditional dementia education (lecture)

Interventions

  • BehavioralVirtual reality dementia simulation with guided reflection

    A single 3-hour VR dementia simulation delivered in three consecutive segments, each followed by guided small-group reflection.

  • BehavioralTraditional dementia education (lecture)

    Instructor-led lecture of equal duration

06

What researchers measure

Primary outcomes

  1. Change in empathy, measured by Jefferson Scale of Empathy

    Empathy is one of the major outcomes which we expect to be improved after the VR education program on dementia. The Jefferson Scale of Empathy (JSE): This scale is used to assess the empathy in caregivers. It is rated on a Likert seven-point scale, with 1 indicating strongly disagree and 7 indicating strongly agree. The scale consists of 20 items and is divided into three major dimensions: perspective taking, compassionate care, and standing in the patient's shoes. The total score ranges from 20 to 140, with higher scores indicating a more positive level of empathy.

    Time frame: Immediate post-session

  2. Change in empathy, measured by Jefferson Scale of Empathy at 1 month

    Empathy is one of the major outcomes which we expect to be improved after the VR education program on dementia. The Jefferson Scale of Empathy (JSE): This scale is used to assess the empathy in caregivers. It is rated on a Likert seven-point scale, with 1 indicating strongly disagree and 7 indicating strongly agree. The scale consists of 20 items and is divided into three major dimensions: perspective taking, compassionate care, and standing in the patient's shoes. The total score ranges from 20 to 140, with higher scores indicating a more positive level of empathy.

    Time frame: 1 month post-session

  3. Change in attitude, measured by Approach to Dementia Questionnaire

    Approach is one of the major outcomes which we expect to be improved after the VR education program on dementia. The Approach to Dementia Questionnaire (ADQ) is used to assess attitudes toward dementia care. The questionnaire consists of two dimensions: hope and person-centeredness, with a total of 19 items. It is rated on a Likert five-point scale, with 1 indicating strongly disagree and 5 indicating strongly agree. The total score ranges from 19 to 95, with higher scores indicating a more positive attitude of caregivers toward dementia care.

    Time frame: Immediate post-session

  4. Change in attitude, measured by Approach to Dementia Questionnaire at 1 month

    Approach is one of the major outcomes which we expect to be improved after the VR education program on dementia. The Approach to Dementia Questionnaire (ADQ) is used to assess attitudes toward dementia care. The questionnaire consists of two dimensions: hope and person-centeredness, with a total of 19 items. It is rated on a Likert five-point scale, with 1 indicating strongly disagree and 5 indicating strongly agree. The total score ranges from 19 to 95, with higher scores indicating a more positive attitude of caregivers toward dementia care.

    Time frame: 1 month post-session

Secondary outcomes

  1. Change in Caregivers' burden, measured by Zarit Burden Interview

    We also expect that caregivers' burden would be reduced after the VR education program on dementia. Zarit Burden Inventory (ZBI): Developed by Zarit et al. in 1980, this inventory is used to measure negative emotions and perceived stress experienced by caregivers in the caregiving process. The ZBI consists of 22 items, and each item is rated on a scale of 0 to 4 based on the frequency of occurrence, ranging from "never" to "routinely." The total score ranges from 0 to 88, with higher scores indicating a greater caregiver burden. Scores between 0 and 20 indicate no or minimal burden, scores between 21 and 40 indicate mild to moderate burden, scores between 41 and 60 indicate moderate to severe burden, and scores between 61 and 88 indicate severe burden.

    Time frame: Baseline and 1 month post-session

  2. Caregivers' mental health status, measured by Brief Symptom Rating Scale-5

    We also expect that caregivers' mental health status would be improved after the VR education program on dementia. The BSRS-5 is a concise self-administered questionnaire adapted from the 50-item brief symptom rating scale. It assesses anxiety, depression, hostility, interpersonal sensitivity, and other symptoms, with scores for each item ranging from 0 to 4. A total BSRS-5 score exceeding 14 or a score of 1 or more on the suicide survey item may signal a severe mood disorder. Scores between 10 and 14 suggest moderate mood disorders, while scores between 6 and 9 may indicate mild mood disorders.

    Time frame: Baseline and 1 month post-session

07

Study locations

1 site
  • Taipei Medical University
    Taipei, Taiwan
08

References and documents

Publications

  • Bai D, Chiu HL, Lin SC, Tan Cheng Kian K, Hsu YL, Lin GH. Enhancing empathy and attitudes toward dementia among formal caregivers through virtual reality: a randomized controlled trial. Innov Aging. 2025 Dec 15;10(4):igaf145. doi: 10.1093/geroni/igaf145. eCollection 2026. PubMed 41873384 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Jan 13, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06072274
Lead sponsor
Taipei Medical University
Responsible party
Sponsor
First posted
Oct 10, 2023
Start date
Dec 9, 2023
Primary completion
Mar 16, 2024
Completion
Mar 16, 2024
Last update
Jan 13, 2026

Study contacts

Dorothy Bai, PhD
principal investigator · Taipei Medical University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Jan 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion